← Leaderboards
Arthur W. Nienhuis
St. Jude Children'S Research Hospital
$5,923,134
Attributed
$5,923,134
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.4M · FY2005–15$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$45,684,920 · 6
By mechanism
P30$22,279,271 · 1
P01$21,272,622 · 4
R01$2,133,027 · 1
Top collaborators
No co-investigators on record.
Most similar at St. Jude Children'S Research Hospital
Same institution · by research overlap
- Brian P Sorrentino$13,809,294
- Derek A Persons$6,676,571
- John Michael Cunningham$4,118,371
- Phillip A Doerfler$1,035,814
- Alessandra D'azzo$11,375,286
Others in their field
Top investigators on “Gene Therapy”
- David Heimbrook · Leidos Biomedical Research, Inc.$164,199,916
- Gregory H Reaman · National Childhood Cancer Foundation$155,841,493
- Randall J Bateman · Washington University$122,781,098
- Eric Martin McDade · Washington University$94,632,845
- Ronald G Crystal · Weill Medical College Of Cornell Univ$82,649,124
- Robert B. Diasio · University Of Alabama At Birmingham$73,470,685
Research focus
Gene TherapySickle Cell AnemiaPromotor (Genetics)Vector GenomeGenesMediatingVectorDesignMonitorBaseGene TransferGene ExpressionClinical ResearchCellular TransductionCellsHematopoieticGenetically Modified CellsGlobinHematopoietic Stem CellsAutologousBone Marrow CellsElementsEnhancersClinical Trials
Grant awards (34)
Gene Transfer for Galactosialidosis - Resub$711,009
R01 · FY2015 · DK · contact PI
Gene Transfer for Galactosialidosis - Resub$711,009
R01 · FY2014 · DK · contact PI
Development of gene therapy for wiskott-aldrich syndrome (WAS)$365,043
P01 · FY2014 · HL · contact PI
Gene Transfer for Galactosialidosis - Resub$711,009
R01 · FY2013 · DK · contact PI
Development of gene therapy for wiskott-aldrich syndrome (WAS)$342,063
P01 · FY2013 · HL · contact PI
Development of gene therapy for wiskott-aldrich syndrome (WAS)$355,462
P01 · FY2012 · HL · contact PI
Development of gene therapy for wiskott-aldrich syndrome (WAS)$348,064
P01 · FY2011 · HL · contact PI
Development of gene therapy for wiskott-aldrich syndrome (WAS)$352,716
P01 · FY2010 · HL · contact PI
Gene Therapy for Sickle Cell Disease$2,137,357
P01 · FY2008 · HL · contact PI
Gene Transfer into Hematopoietic Stem Cells$306,500
P01 · FY2008 · HL · contact PI
Gene Therapy for Sickle Cell Disease$2,120,936
P01 · FY2007 · HL · contact PI
Gene Transfer into Hematopoietic Stem Cells$311,865
P01 · FY2007 · HL · contact PI
Gene Therapy for Sickle Cell Disease$2,124,230
P01 · FY2006 · HL · contact PI
Gene Transfer into Hematopoietic Stem Cells$312,636
P01 · FY2006 · HL · contact PI
Gene Therapy for Sickle Cell Disease$2,115,664
P01 · FY2005 · HL
Gene Transfer into Hematopoietic Stem Cells$303,534
P01 · FY2005 · HL
St.Jude Children's Cancer Center Support Grant (CCSG)$4,880,151
P30 · FY2004 · CA
Gene Therapy for Sickle Cell Disease$2,067,487
P01 · FY2004 · HL
Gene Transfer into Hematopoietic Stem Cells$294,692
P01 · FY2004 · HL
St.Jude Children's Cancer Center Support Grant (CCSG)$90,000
P30 · FY2004 · CA
ADMINISTRATION CORE$42,842
P01 · FY2004 · HL
St.Jude Children's Cancer Center Support Grant (CCSG)$4,758,536
P30 · FY2003 · CA
GENE THERAPY FOR SICKLE CELL DISEASE$1,806,622
P01 · FY2003 · HL
St.Jude Children's Cancer Center Support Grant (CCSG)$90,000
P30 · FY2003 · CA
St.Jude Children's Cancer Center Support Grant (CCSG)$4,612,379
P30 · FY2002 · CA
GENE THERAPY FOR SICKLE CELL DISEASE$1,753,998
P01 · FY2002 · HL
GENE TRANSFER INTO HEMATOPOIETIC STEM CELLS$126,320
P01 · FY2002 · HL
St.Jude Children's Cancer Center Support Grant (CCSG)$89,800
P30 · FY2002 · CA
ST JUDE CHILDRENS CANCER CENTER SUPPORT GRANT (CCSG)$3,922,679
P30 · FY2001 · CA
GENE THERAPY FOR SICKLE CELL DISEASE$1,702,910
P01 · FY2001 · HL
GENE TRANSFER INTO HEMATOPOIETIC STEM CELLS$126,320
P01 · FY2001 · HL
ST JUDE CHILDRENS CANCER CENTER SUPPORT GRANT (CCSG)$3,835,726
P30 · FY2000 · CA
GENE THERAPY FOR SICKLE CELL DISEASE$1,653,311
P01 · FY2000 · HL
GENE TRANSFER INTO HEMATOPOIETIC STEM CELLS$202,050
P01 · FY2000 · HL